Systemic autoimmune rheumatic diseases (SARDs) exhibit extensive heterogeneity in
clinical presentation, disease course, and treatment response. Therefore, precision …

Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical
features, which complicates psoriasis in 30% of patients. There are no diagnostic criteria or …

For many oncological conditions, the application of timely and patient-tailored targeted
therapies, or precision medicine, is a major therapeutic development that has provided …

Systemic inflammation plays a central role in the pathophysiology of psoriasis. This study
examined accessible systemic inflammatory markers in patients with psoriasis vulgaris and …

Psoriatic arthritis (PsA) is a heterogeneous disease involving multiple potential tissue
domains. Most outcome measures used so far in randomized clinical trials do not sufficiently …

Psoriatic arthritis (PsA) is a heterogenous systemic inflammatory disorder which affects
peripheral joints (PsA) and skin (psoriasis (Ps)), but also causes inflammation at entheseal …

Spondyloarthritis (SpA) is characterized by the infiltration of innate and adaptive immune
cells into entheses and bone marrow. Molecular, cellular and imaging evidence …

Background Psoriasis and insulin resistance (IR) are closely related, but it remains unclear
whether IR affects the treatment of patients with psoriasis. Objective To investigate whether …

Background Psoriasis is an inflammatory disease associated with multiple comorbidities.
Biomarkers for the assessment of psoriasis, its associated comorbidities, and the therapeutic …

Objective Several advanced therapies have been licensed across the related conditions of
psoriatic arthritis (PsA), Crohn disease (CD), ulcerative colitis (UC), and noninfectious …